Pharsight

Movantik patents expiration

MOVANTIK's oppositions filed in EPO
MOVANTIK IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7662365 VALINOR Polymer conjugates of opioid antagonists
Oct, 2022

(1 year, 7 months ago)

US7786133 VALINOR Chemically modified small molecules
Sep, 2028

(4 years from now)

US9012469 VALINOR Crystalline naloxol-peg conjugate
Apr, 2032

(7 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617530 VALINOR Polymer conjugates of opioid antagonists
Oct, 2022

(1 year, 7 months ago)

US7056500 VALINOR Polymer conjugates of opioid antagonists
Jun, 2024

(13 days from now)

US8067431 VALINOR Chemically modified small molecules
Dec, 2024

(6 months from now)

Movantik is owned by Valinor.

Movantik contains Naloxegol Oxalate.

Movantik has a total of 6 drug patents out of which 2 drug patents have expired.

Expired drug patents of Movantik are:

  • US8617530
  • US7662365

Movantik was authorised for market use on 16 September, 2014.

Movantik is available in tablet;oral dosage forms.

Movantik can be used as treatment of opioid-induced constipation.

Drug patent challenges can be filed against Movantik from 16 September, 2018.

The generics of Movantik are possible to be released after 02 April, 2032.

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Sep 16, 2019

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using NALOXEGOL OXALATE ingredient

NCE-1 date: 16 September, 2018

Market Authorisation Date: 16 September, 2014

Treatment: Treatment of opioid-induced constipation

Dosage: TABLET;ORAL

How can I launch a generic of MOVANTIK before it's drug patent expiration?
More Information on Dosage

MOVANTIK family patents

Family Patents